medigraphic.com
SPANISH

Revista del Hospital Juárez de México

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 3

<< Back Next >>

Rev Hosp Jua Mex 2013; 80 (3)

Manejo anestésico del craneofaringioma infantil

Reynoso-Romero D, Castillo-Espinosa M, Escobar-de la Garma VH, Moctezuma-Ramírez L
Full text How to cite this article

Language: Spanish
References: 8
Page: 202-205
PDF size: 290.79 Kb.


Key words:

Childhood craniopharyngioma, anesthetic implications, hypothyroidism, diabetes insipidus, panhypopituitarism, sellar region.

ABSTRACT

Craniopharyngioma counts for 5 to 10% of intracranial tumors in children and is the third most common tumour in childhood. Craniopharyngioma can cause endocrine abnormalities such as hypothyroidism, somatropin deficiency, corticotropin deficiency and diabetes insipidus (in 90% of cases appears 2-3 days after surgery) and also present anesthetic implications such as cardiovascular disorders and airway management. Multidisciplinary management should be performed in these settings, to avoid endocrine complications and acid-base disorders. Here, the role of the anesthesiologist is vital to provide adequate patient care, minimizing risks and complications of the disease during the perioperative stage.


REFERENCES

  1. Rivero C, Ramos P, Solla G. Guía para la evaluación y preparación preoperatoria de los pacientes neuroquirúrgicos de coordinación. Anestesia, Analgesia y Reanimación 2011; 24(1).

  2. Zoran SG, Danilovski D, Tasic V, Ugrinovski J, Nastova V, Jancevska A, et al. Childhood craniopharyngioma in Macedonia: incidence and outcome after subtotal resection and cranial irradiation. World J Pediatr 2011; 7(1).

  3. Tena ML, Moreno RI, Rembao D, Vega R, Moreno S, Castillejos MJ, et al. Craneofaringioma, estudio clínico-patológico. Quince años del Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suárez”. Gac Med Mex 2009; 145(5).

  4. Yang I, Sughrue ME, Rutkowski MJ, Kaur R, Ivan ME, Aranda D, Baran, et al. Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus 2010; 28(4): E5.

  5. Elliott RE, Jane JA, Wisoff JH. Surgical Management of craniopharyngiomas in Children: meta-analysis and comparison of transcranial and transsphenoidal approaches. Neurosurgery 2011; 69: 630-43.

  6. Bahena AB, Tamez HE, Sánchez LM, Quintanilla DL, Mayra I, Hernández MI, Cisneros JM, et al. Tamaño tumoral y su asociación con deficiencia hormonal hipofisaria postquirúrgica de craneofaringioma en niños. Revista de Endocrinología y Nutrición 2011; 19(2): 58-61.

  7. Pettorini BL, Paolo Frassanito P, Caldarelli M, Tamburrini G, Luca Massimi L, Di Rocco C. Molecular pathogenesis of craniopharyngioma: switching from a surgical approach to a biological one. Neurosurg Focus 2010; 28(4): E1.

  8. Elliott RE, Sands SA, Strom RG, Wisoff JH. Craniopharyngioma Clinical Status Scale: a standardized metric of preoperative function and post treatment outcome. Neurosurg Focus 2010; 28(4): E2.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Hosp Jua Mex. 2013;80